Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study - Top-Institutions - MDSpire

Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study

  • By

  • Michele Molinari

  • Vrishketan Sethi

  • Christof Kaltenmeier

  • Abiha Abdullah

  • Berkay Demirors

  • Matthew Yu-Sheng Lin

  • Jason Mial-Anthony

  • Dooman Arefan

  • Shandong Wu

  • Christopher Buros

  • Hao Liu

  • Charbel Elias

  • Marta Minervini

  • Samer Tohme

  • Xingyu Zhang

  • David Geller

  • Alessandro Furlan

  • July 16, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital RWTH Aachen
    University Hospital RWTH Aachen

    Aachen, North Rhine-Westphalia

    Key Differentiators

    • Hepatology

  • #2

    RWTH-Aachen University
    RWTH-Aachen University

    Aachen, North Rhine-Westphalia

    Key Differentiators

    • Hepatology

  • #3

    Sun Yat-sen University
    Sun Yat-sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Hepatology

  • #4

    University Hospital Duesseldorf
    University Hospital Duesseldorf

    Düsseldorf, North Rhine-Westphalia

    Key Differentiators

    • Hepatology

  • #5

    Heinrich-Heine-University Duesseldorf
    Heinrich-Heine-University Duesseldorf

    Düsseldorf, North Rhine-Westphalia

    Key Differentiators

    • Hepatology

Original Source(s)

Survival after curative hepatectomy for hepatocellular carcinoma in patients with and without MAFLD: a western cohort study

  • by Michele Molinari, Vrishketan Sethi, Christof Kaltenmeier, Abiha Abdullah, Berkay Demirors, Matthew Yu-Sheng Lin, Jason Mial-Anthony, Dooman Arefan, Shandong Wu, Christopher Buros, Hao Liu, Charbel Elias, Marta Minervini, Samer Tohme, Xingyu Zhang, David Geller, Alessandro Furlan

  • July 16, 2026

Related Content

Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

The prognostic significance of immunohistochemical expressions of proliferating cell nuclear antigen, P16 and Ki-67 in breast cancer